-1.13237458951318E-05 0.000656777261918289 0.00115502208130447 0.00124561204846566 -0.00185709432680329 0.000135884950741711 0.000385007360434868 -0.00245725285924579
Sign Up Today X
Thanks for submitting the form.
Stockreport

Tevogen Bio Strengthens Robust IP Portfolio With Filing of Predictive AI Patent, With the Goal to Establish a Blueprint to Unlock the Full Potential of T Cell Therapies and Accelerate AI I...

Microsoft Corporation (MSFT)  More Company Research Source: Yahoo! Finance
Last microsoft corporation earnings: 4/29 04:06 pm Check Earnings Report
US:NASDAQ Investor Relations: microsoft.com/en-us/investor
Tevogen Bio has filed a patent for a predictive AI system to enhance its T cell therapies, aiming to accelerate innovation and improve patient accessibility. The company has been investing in AI initiatives, including a partnership with Microsoft, and has appointed a new head of AI with over 20 years of experience. Tevogen Bio believes that combining its biopharma expertise with AI can lead to breakthroughs and establish the company as a leader in the field. The company plans to provide updates on its AI efforts at the J.P. Morgan Healthcare Conference in January 2025. Generated by Yahoo Finance AI Yahoo Finance used generative AI to summarize key information from this article. Some details may be inaccurate. We take that seriously. Reporting mistakes helps us improve these summaries. Was this helpful? Yes No Tevogen Bio Inc WARREN, N.J., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN ), a clinical-stage specialty [Read more]
IMPACT SNAPSHOT EVENT TIME: MSFT
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
MSFT alerts
from News Quantified
MSFT
NEWS
MSFT
Earnings
MSFT
Analyst Actions
MSFT
SEC Filings
Stockreport

Tevogen Bio Strengthens Robust IP Portfolio With Filing of Predictive AI Patent, With the Goal to Establish a Blueprint to Unlock the Full Potential of T Cell Therapies and Accelerate AI I...

Microsoft Corporation  (MSFT) 
More Company Research Source: Yahoo! Finance
Last microsoft corporation earnings: 4/29 04:06 pm Check Earnings Report
US:NASDAQ Investor Relations: microsoft.com/en-us/investor
Tevogen Bio has filed a patent for a predictive AI system to enhance its T cell therapies, aiming to accelerate innovation and improve patient accessibility. The company has been investing in AI initiatives, including a partnership with Microsoft, and has appointed a new head of AI with over 20 years of experience. Tevogen Bio believes that combining its biopharma expertise with AI can lead to breakthroughs and establish the company as a leader in the field. The company plans to provide updates on its AI efforts at the J.P. Morgan Healthcare Conference in January 2025. Generated by Yahoo Finance AI Yahoo Finance used generative AI to summarize key information from this article. Some details may be inaccurate. We take that seriously. Reporting mistakes helps us improve these summaries. Was this helpful? Yes No Tevogen Bio Inc WARREN, N.J., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN ), a clinical-stage specialty [Read more]
IMPACT SNAPSHOT
EVENT TIME:
MSFT
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS